SAT0734-HPR THE EFFECT OF RHEUMATIC DISEASES ON WORK ABILITY: A STUDY OF SELF-ASSESSMENT OF SF-36 IN PATIENTS WITH SMART SYSTEM OF DISEASE MANAGEMENT (SSDM)
Background: A variety of rheumatic diseases can significantly affect the patient's quality of life and work ability. SF-36 is a commonly used tool to assess the quality of life and work ability in patients with chronic disease. In the past, most patients were guided by doctors/nurses to assess SF-36 in a paper form. At present, there is a lack of research on the quality of life in patients with rheumatic diseases by using new mobile tools in the real world. Objectives: To explore the effect to the life ability of rheumatic disease and the potential association between the disease activity and SF-36 in patients with rheumatoid arthritis (RA) using SSDM. Methods: SSDM is a new smart disease management mobile tool, which includes physicians' and patients' application system. After entering the results of SF-36 assessment by patients, all data can be synchronized automatically to the mobile terminal of authorized rheumatologist. According to the scores of SF-36 (<12.5, 12.5-50 and >50), the quality of life was divided into three levels: poor, moderate and good. Results: From June 2016 January 2017, data were extracted online from the mobile terminals of 839 adult patients (284 male and 555 female) in 62 hospitals across China. All patients performed self-assessment of SF-36 for a total of 1,065 times. The mean age was 38.12±13.87 (18 to 81) years and the median disease duration was 20.60 (0 to 573) months. There are 25 kinds of rheumatic diseases involved, including RA (23%), ankylosing spondylitis (AS, 19%), systemic lupus erythematosus (SLE, 13%), osteoarthritis (OA, 11%), Sjogren syndrome (SS, 10%), polymyositis/dermatomyositis (PM/DM, 6%), mixed connective tissue disease (MCTD, 6%) and others (12%). The 8 items of SF-36 index were averaged between 49.07 (General Health perceptions, GH) to 74.12 (Physical Functioning, PF). The overall mean score of patients with different rheumatic diseases was higher than 50. However, there were 5 kinds of rheumatic diseases with average score of 5 items less than 50, including: MCTD, SS, PM/DM, AS and SLE in patients with GH score: 44. 24 Background: The applicability of ultrasonography in diagnosis and monitoring of rheumatic diseases has been steadily growing but little is known about the patient's perspective. Objectives: To assess the patient's knowledge of the ultrasound (US) method and its clinical applicability as well as to evaluate how much was learned after a lecture. Methods: Patients with rheumatic diseases were invited to an educational meeting that included an US lecture. They were asked to fill out a questionnaire before and after the 35-minute lecture about US and its clinical uses. The questionnaire included questions about their disease and treatment, their educational background (years of study) and ten questions about US and its clinical uses (table).These ten questions had to be answered with "yes", "no", or "I am not sure". Results: A total of 70 patients attended the lecture and answered the questionnaires. Their demographic characteristics were as follows: Mean ± SD: age 63±12 years, disease duration: 9.6±0.8 years, the most frequent self-reported diagnosis was rheumatoid arthritis (57,2%), while osteoarthritis accounted for another 20%. Most patients had only eight years of study (64.3%) and a university degree was reported by 14%. The questionnaire responses of 66 patients with rheumatic diseases were analysed. There was a noticeable increase in the positive responses to these questions: 1, 2, 3 and 7, after the lecture, 44%
